
Nov 13, 2026 · 48 min
Menopause care demands better evaluation, not dismissal
HRT, IUDs & Testosterone in Menopause with Dr. Fran Haydanek
Perimenopause symptoms can overlap with serious conditions and other health problems, making informed, individualized care more consequential than a single lab result.
- 1Irregular bleeding may be expected in perimenopause, but heavy or postmenopausal bleeding warrants evaluation for conditions including endometrial cancer.
- 2Hormone therapy, contraception, IUDs, and nonhormonal treatments should be matched to symptoms, risks, reproductive goals, and informed preferences.
- 3Normal labs and persistent symptoms do not end the conversation; menopause expertise and a second opinion can change care.
Don't miss
The clinicians acknowledge that social-media accounts of undertreated pain during IUD insertions and biopsies helped prompt changes in practice and professional guidance.
The brief
Perimenopause can disrupt bleeding patterns, but heavy or postmenopausal bleeding is not something to normalize—especially when fibroids, polyps, or endometrial cancer are possible.
Fran Haydanek argues that normal hormone tests can wrongly end evaluation, while exhaustion, anxiety, and poor sleep may also reflect sleep apnea, iron deficiency, depression, or heavy periods.
The treatment discussion connects contraception, IUDs, estrogen, progesterone, SSRIs, gabapentin, fezolinetant, and testosterone to individualized risk-benefit decisions rather than one universal regimen.
The conversation revisits hormone-therapy fears surrounding the Women’s Health Initiative, emphasizing absolute risks, informed consent, and the difference between estrogen-only and estrogen-plus-progestin findings.
It also treats inadequate pain control for IUD insertions and biopsies as a medical issue, then closes with a practical prescription: seek menopause-informed care when symptoms are dismissed.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.